TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...
As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn acquisition of ...
Third quarter earnings season is ramping up, and analysts expect S&P 500 companies grew their profits by 8% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback